ReviewDiabetology & metabolic syndrome2023

Efficacy and tolerability of the Subcutaneous Semaglutide for type 2 Diabetes patients: an updated systematic review and meta-analysis.

Shanshan Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.